Refractory anemia with excess of blasts in transformation: analysis of reclassification according to the WHO proposals.
Strupp C, Gattermann N, Giagounidis A, Aul C, Hildebrandt B, Haas R, Germing U.
Leuk Res. 2003 May;27(5):397-404. doi: 10.1016/s0145-2126(02)00220-5.
Biological characterization of refractory anemia with excess of blasts.
Maiolo AT, Foa P, Pagetti D, Baldini L, Mozzana R, Ortolani S, Colantoni A, Lombardi L, Lavezzi AM, Polli EE.
Haematologica. 1987 Nov-Dec;72(6 Suppl):126-9.
Outcome of children with refractory anaemia with excess of blast (RAEB) and RAEB in transformation (RAEB-T) in the Japanese MDS99 study.
Kikuchi A, Hasegawa D, Ohtsuka Y, Hamamoto K, Kojima S, Okamura J, Nakahata T, Manabe A; Japanese Paediatric Myelodysplastic Syndrome (MDS) Study Group.
Br J Haematol. 2012 Sep;158(5):657-61. doi: 10.1111/j.1365-2141.2012.09210.x. Epub 2012 Jun 26.
Refractory anemia with excess of blasts in transformation. Clinical, hematologic, and cytogenetic findings in nine patients.
Smadja N, Krulik M, de Gramont A, Gonzalez-Canali G, Audebert AA, Debray J.
Cancer Genet Cytogenet. 1989 Oct 1;42(1):55-65. doi: 10.1016/0165-4608(89)90008-3.
Azacitidine versus decitabine in patients with refractory anemia with excess blast-Results of multicenter study.
Salim O, Toptas T, Avsar E, Yucel OK, Ozturk E, Ferhanoglu B, Geduk A, Mehtap O, Tombak A, Tiftik EN, Deveci B, Kurtoglu E, Kara O, Atagunduz IK, Tuglular TF, Undar L.
Leuk Res. 2016 Jun;45:82-9. doi: 10.1016/j.leukres.2016.04.003. Epub 2016 Apr 11.
Immunologic characteristics and prognosis of myelodysplastic syndrome new subtype: refractory anemia with excess blasts-II.
Wei J, Zhou XF, Zhao F, Zhou JF, Chen Y.
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Feb;17(1):111-6.
Characterization of clonogenic cells in refractory anemia with excess of blasts (RAEB-CFU): response to recombinant hematopoietic growth factors and maturation phenotypes.
Schouten HC, Delwel R, Bot FJ, Hagemeijer A, Touw IP, Löwenberg B.
Leuk Res. 1989;13(3):245-51. doi: 10.1016/0145-2126(89)90019-2.
Acquired elliptocytosis in the setting of a refractory anemia with excess blasts and del(20q).
Boutault R, Eveillard M.
Blood. 2016 May 26;127(21):2646. doi: 10.1182/blood-2016-03-703876. Epub 2016 May 26.
Myeloid Sarcoma of the Bladder in the Setting of Refractory Anemia with Excess Blasts-2 (RAEB-2).
Grantham JT, Howell DM, Bacaj PJ, Coad JE, Vos JA.
W V Med J. 2015 Nov-Dec;111(6):34-6.
Re-evaluation of refractory anemia with excess blasts in transformation.
Ohyashiki K, Nishimaki J, Shoji N, Miyazawa K, Kimura Y, Ohyashiki JH.
Leuk Res. 2001 Nov;25(11):933-9. doi: 10.1016/s0145-2126(01)00054-6.
